Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus
- 1 September 2004
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 44 (5), 1047-1052
- https://doi.org/10.1016/j.jacc.2004.05.071
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Screening for treatable left ventricular abnormalities in diabetic patientsExpert Opinion on Biological Therapy, 2003
- Utility of B-Natriuretic Peptide in Detecting Diastolic DysfunctionCirculation, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Guidelines for the diagnosis and treatment of chronic heart failurePublished by Oxford University Press (OUP) ,2001
- Brain natriuretic peptide predicts mortality in the elderly.Heart, 1997
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.JCI Insight, 1995
- Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)The American Journal of Cardiology, 1991
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974